CLINICAL_TRIALS
trial_result
· 2018-11-19
Clinical Trial Update: Study Evaluating Safety And Tolerability, Solid Tumor [Phase 1]
Summary
A Phase 1 trial evaluating safety and tolerability in patients with advanced malignant solid tumors has been completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Puma Biotechnology, Inc. | Conditions: Advanced Malignant Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2018-11-19